Medcura, Inc., a medical device company developing versatile hemostatic products, has established an advisory board of top spine surgeons to consult as its absorbable hemostatic gel LifeGel™ goes through clinical trials, regulatory review, and, potentially, commercialization.
The new spinal surgery advisory board includes nine spine surgeons who are experts in clinical trial strategy and medical device design.
Subscribe to continue reading
- Unlimited access to our content and archive
- Exclusive access to our newsletter
- Join the Conversation! Exclusive access to article comments.
